Bottom line
How much do IBB and HTEC overlap?
20% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 22.8% of IBB's assets and 14.2% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.
IBB holds far more positions (254 vs 63), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBB and HTEC have in common
| Holding | % of IBB | % of HTEC | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals, Inc. | 7.66% | 1.91% | 1.91% |
| Regeneron Pharmaceuticals, Inc. | 5.70% | 1.97% | 1.97% |
| IQVIA Holdings, Inc. | 3.18% | 2.10% | 2.10% |
| Natera, Inc. | 2.11% | 2.23% | 2.11% |
| Incyte Corp. | 1.62% | 1.80% | 1.62% |
| Illumina, Inc. | 1.41% | 2.09% | 1.41% |
| Medpace Holdings, Inc. | 1.16% | 2.12% | 1.16% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBB
- BlackRock Funds III — 13.18%
- Gilead Sciences, Inc. — 7.52%
- Amgen, Inc. — 7.50%
- Alnylam Pharmaceuticals, Inc. — 5.68%
- Argenx SE — 3.15%
- Insmed, Inc. — 2.95%
- Mettler-Toledo International, Inc. — 2.49%
- BeOne Medicines Ltd. — 2.11%
- Biogen, Inc. — 2.03%
- United Therapeutics Corp. — 1.82%
- Waters Corp. — 1.77%
- Genmab A/S — 1.38%
- Neurocrine Biosciences, Inc. — 1.34%
- Exelixis, Inc. — 1.07%
- Ionis Pharmaceuticals, Inc. — 1.03%
Only in HTEC
- Caredx, Inc. — 2.68%
- Guardant Health, Inc. — 2.31%
- Twist Bioscience Corp — 2.23%
- Thermo Fisher Scientific Incorporated — 2.18%
- Adaptive Biotechnologies Corporation — 2.11%
- Arrowhead Pharmaceuticals, Inc. — 2.08%
- Glaukos Corporation — 1.92%
- Stryker Corporation — 1.91%
- Livanova Plc — 1.87%
- Siemens Healthineers AG — 1.85%
- Lonza Group AG — 1.85%
- Abbott Laboratories — 1.79%
- AxoGen, Inc. — 1.77%
- Boston Scientific Corporation — 1.73%
- Grail Inc — 1.72%
Asset mix
| Asset type | IBB | HTEC |
|---|---|---|
| Stocks | 99.8% | 99.8% |
| Cash & short-term funds | 13.4% | 0.2% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Country mix
| Country | IBB | HTEC |
|---|---|---|
| US | 98.6% | 82.9% |
| CH | 2.7% | 5.0% |
| NL | 4.3% | 1.6% |
| HK | — | 3.7% |
| DK | 2.2% | — |
| DE | 0.7% | 1.9% |
| FR | — | 1.6% |
| IT | — | 1.3% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Check another pair
FAQ
How much do IBB and HTEC overlap?
What stocks do IBB and HTEC have in common?
Should I own both IBB and HTEC?
Which holds more stocks, IBB or HTEC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.